The risk of NAFLD in the subgroup with a higher irisin concentration was found to be above 4 times higher than that in the subgroup with a low concentration of irisin (odds: 1.52 and 0.33 respectively; OR = 4.57). This evidence concerns the gene FNDC5 and metabolic dysfunction-associated steatotic liver disease.